Absci Corp
Biotechnology
Healthcare
ABSI
114 M shares
NASDAQ US
traded
15 Apr 2025
listed
no
open
3.03
52 week high
5.79
high
3.30
52 week low
2.24
low
2.98
growth
-28.77 %
previous Close
3.09
P/E ratio
market cap
343 M
div yield
0
usd
Sep 2024
qoq
revenue
1.70 M
33.94 %
net incoming
-27.40 M
-10.70 %
eps
0.00 %
-9.64 %
eps surprise
-14.86 %
net profit margin
-1610.70 %
338.00 %
operating incoming
-28.90 M
-8.14 %
net change in cash
-5.44 M
65.42 %
cash on hand
38.20 M
-11.04 %
cost of revenue
0.00 %
top top